FdaApplication
BLA 761043
Identifiers
- fda_app_no: BLA761043
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline LLC |
| application_type | BLA |
| approval_date | 2017-07-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BENLYSTA | BELIMUMAB | 200MG/ML | Injection |
| BENLYSTA | — | 200MG/ML | Injection |
2 products